Talphera TLPH
NASDAQ TLPH
$1.24 +0.02 (+1.64%)
At close: Sep 10, 2026 · 4:00 PM EDT

Talphera (TLPH) Capital Expenditures (2011 - 2023)

Talphera (TLPH) posted Capital Expenditures of $100000.0 for Q1 2023, up 108.33% on a QoQ basis from $48000.0 in Q4 2022, and up 12.36% year-over-year from $89000.0 in Q1 2022.

Analysis

Talphera (TLPH) Capital Expenditures (2011 - 2023) Analysis & Trends

Talphera has reported Capital Expenditures for 13 years, with the latest figure at $100000.0 in Q1 2023.

  • On a quarterly basis, Capital Expenditures rose 12.36% year-over-year to $100000.0 in Q1 2023; TTM through Dec 2023 was $100000.0, a 72.53% decrease from a year earlier, with the FY2023 full-year figure at $100000.0, down 72.53% from the prior year.
  • Capital Expenditures was $100000.0 for Q1 2023 at Talphera, up from $48000.0 in the prior quarter.
  • The five-year high for Capital Expenditures was $1.6 million in Q4 2020, with the low at $24000.0 in Q1 2021.
  • Average Capital Expenditures over 5 years is $448000.0, with a median of $100000.0 recorded in 2023.
  • The largest YoY upside for Capital Expenditures was 1540.21% in 2021 against a maximum downside of 98.28% in 2021.
  • Over 5 years, Capital Expenditures stood at $242000.0 in 2019, then surged by 573.97% to $1.6 million in 2020, then tumbled by 98.28% to $28000.0 in 2021, then surged by 71.43% to $48000.0 in 2022, then soared by 108.33% to $100000.0 in 2023.
  • The last three Capital Expenditures figures came in at $100000.0 (Q1 2023), $48000.0 (Q4 2022), and $158000.0 (Q3 2022), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 513.00 Mn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 140.00 Mn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 112.20 Mn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 240.20 Mn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 37.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 34.68 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 40.90 Mn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn -1.87 Mn
10 Talphera 92.90 Mn 92.90 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 100,000.00
Dec 31, 2022 48,000.00
Sep 30, 2022 158,000.00
Jun 30, 2022 69,000.00
Mar 31, 2022 89,000.00
Dec 31, 2021 28,000.00
Sep 30, 2021 184,000.00
Jun 30, 2021 1.59 Mn
Mar 31, 2021 24,000.00
Dec 31, 2020 1.63 Mn
Sep 30, 2020 54,000.00
Jun 30, 2020 97,000.00
Mar 31, 2020 73,000.00
Dec 31, 2019 242,000.00
Sep 30, 2019 1.44 Mn
Jun 30, 2019 1.13 Mn
Mar 31, 2019 658,000.00
Dec 31, 2018 246,000.00
Sep 30, 2018 186,000.00
Jun 30, 2018 179,000.00